(Q35546926)

8 August 2017

title

Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect (English)

1 reference

8 August 2017

1 reference

Soo K Bae

1

1 reference

8 August 2017

Won-Suk Chung

2

1 reference

8 August 2017

Eun J Kim

3

1 reference

8 August 2017

Jae K Rhee

4

1 reference

8 August 2017

Jong W Kwon

5

1 reference

8 August 2017

Won B Kim

6

1 reference

8 August 2017

Myung G Lee

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Antimicrobial Agents and Chemotherapy

8 August 2017

published in

1 reference

8 August 2017

volume

48

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

659-662

1 reference

Oxazolidinone antibiotics.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Linezolid: an oxazolidinone antimicrobial agent

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

First-pass metabolism of midazolam by the human intestine.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

New calculation method of mean total body clearance of drugs and its application to dosage regimens.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

High-performance liquid chromatographic analysis of DA-7867, a new oxazolidinone, in human plasma and urine and in rat tissue homogenates

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=321507

Intestinal first-pass effect of bumetanide in rats

26 September 2018

1 reference

12 December 2020

Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats

1 reference

12 December 2020

Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects

1 reference

12 December 2020

New Calculation Method for Mean Apparent Drug Volume of Distribution and Application to Rational Dosage Regimens

1 reference

12 December 2020

Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism

1 reference

12 December 2020

Physiological parameters in laboratory animals and humans

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition

1 reference

12 December 2020

Liver and gastrointestinal first-pass effects of azosemide in rats

1 reference

12 December 2020

Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats

1 reference

12 December 2020

Gastrointestinal first-pass effect of furosemide in rats

1 reference

12 December 2020

10.1128/AAC.48.2.659-662.2004

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference